[Predominant role of delayed-action anti-infectious drugs and medicinal mixtures in bullous toxidermitis with necroepidermolysis (Debré-Lamy-Lamotte syndrome, renamed Lyell's syndrome)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects*; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D003692:Delayed-Action Preparations / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects*; D007223:Infant; D008297:Male; D008875:Middle Aged; D013262:Stevens-Johnson Syndrome
D000700:Analgesics; D000890:Anti-Infective Agents; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D006993:Hypnotics and Sedatives
La part prédominante des anti-infectieux-retards et des cocktails médicamenteux dans les toxidermies bulleuses avec nécro-épidermolyse (syndrome de Debré-Lamy et Lamotte, post nommé syndrome de Lyell.